A collaborative partnership can help ensure that patients get the most up-to-date information on their disease and treatment options.
The relationship between pharmaceutical companies and advocacy groups is important for all stakeholders, but more needs to be done to create truly interactive, transparent relationships. Only then will the connections between these companies, patients, and caregivers grow stronger. Kelli Belsinger, our Account Director, says that our agency’s clients “have been most successful when they approach advocacy groups with a complete openness and transparency.”
“Because of the established relationship between our client’s advocacy group and the patient advocacy groups, they were able to create a successful program that brought together, doctors, advocates, and patients living with the disease to illuminate a variety of important topics.”